Effects of lactoferrin-enriched dairy product on iron status in women with gestational diabetes mellitus.

Authors

Ilaria Goitre, Valentina Ponzo, Ilario Ferrocino, Irene Franciosa, Alessandra Valla, Barbara Giovanna Lucatello, Federico Ragazzoni, Maurilio Deandrea, Valentina Rovei, Erato Maria Stefanidou, Emily Canuto, Luca Marozio, Giulio Mengozzi, Elena Crisà, Anna Sapino, Simona Bo

Published in

NPJ science of food. Jul 14, 2026. Epub Jul 14, 2026.

Abstract

Lactoferrin (LF) is an iron-binding glycoprotein with anti-inflammatory and microbiota-modulating properties, but its effects in gestational diabetes mellitus (GDM) remain unclear. In this double-blind randomized pilot trial (NCT07287384, registered on 11 December 2025), 50 women with GDM (24-30 weeks' gestation) were assigned to receive either an LF-enriched yogurt (100 mg LF/125 g, two servings/day; n = 25) or a control yogurt (n = 25) for eight weeks, alongside 30 mg/day elemental iron. The primary outcome was ferritin change; secondary outcomes included hematologic, metabolic, microbiota, and maternal-neonatal parameters. Forty-six participants completed the study (24 LF, 22 control), with comparable baseline characteristics. Transferrin levels and red blood cell counts increased in both arms. However, ferritin decreased in controls but remained stable in the LF arm, with a significant between-group difference (p = 0.011). Fasting glucose, hemoglobin, and hematocrit were unchanged. Insulin and homeostasis-model-assessment insulin-resistance (HOMA-IR) levels increased modestly within groups without between-group differences. Anemia incidence was similar (20.8% LF vs 27.3% control; p = 0.609). No adverse events occurred. Microbiota diversity was unchanged; LF supplementation increased Lactilactobacillus, Anaerovoracaceae, and was associated with higher Lactobacillus and lower Eggerthella and Actinomyces compared to controls. LF-enriched yogurt was safe, prevented ferritin decline, and modulated selected gut taxa in women with GDM.

PMID:
42448694
Bibliographic data and abstract were imported from PubMed on 15 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.